Radhika Pochampally
Overview
Explore the profile of Radhika Pochampally including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
2674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vallabhaneni K, Penfornis P, Xing F, Hassler Y, Adams K, Mo Y, et al.
Oncotarget
. 2018 Jan;
8(66):109861-109876.
PMID: 29299114
Mesenchymal stromal cells (hMSCs) have been used to understand the stromal cell properties in solid tumors because of their ablity to differentiate into most cell types. We investigated the role...
2.
Vallabhaneni K, Hassler M, Abraham A, Whitt J, Mo Y, Atfi A, et al.
PLoS One
. 2016 Nov;
11(11):e0166027.
PMID: 27812189
Studies have shown that mesenchymal stem/stromal cells (MSCs) from bone marrow are involved in the growth and metastasis of solid tumors but the mechanism remains unclear in osteosarcoma (OS). Previous...
3.
Xu R, Fitts A, Li X, Fernandes J, Pochampally R, Mao J, et al.
Anal Chem
. 2016 Oct;
88(21):10390-10394.
PMID: 27689436
Chemical analysis of small extracellular vesicles (sEVs) circulating in body fluids holds potentials in noninvasive diagnosis of diseases and evaluation of therapeutic treatments. However, quantification of sEVs remains a challenge...
4.
Sharma S, Xing F, Liu Y, Wu K, Said N, Pochampally R, et al.
J Biol Chem
. 2016 Jul;
291(37):19351-63.
PMID: 27422817
Prostate cancer is known to frequently recur in bone; however, how dormant cells switch its phenotype leading to recurrent tumor remains poorly understood. We have isolated two syngeneic cell lines...
5.
Penfornis P, Pochampally R
Methods Mol Biol
. 2016 May;
1416:159-69.
PMID: 27236671
Mesenchymal stem/stromal cells (MSCs) have been extensively investigated for their potential to regenerate tissue, to modulate the immune system, and their wound healing properties in over 350 clinical trials worldwide....
6.
Nawaz M, Fatima F, Vallabhaneni K, Penfornis P, Valadi H, Ekstrom K, et al.
Stem Cells Int
. 2015 Dec;
2016:1073140.
PMID: 26649044
Stem cells are proposed to continuously secrete trophic factors that potentially serve as mediators of autocrine and paracrine activities, associated with reprogramming of the tumor microenvironment, tissue regeneration, and repair....
7.
Konala V, Mamidi M, Bhonde R, Kumar Das A, Pochampally R, Pal R
Cytotherapy
. 2015 Dec;
18(1):13-24.
PMID: 26631828
The unique properties of mesenchymal stromal/stem cells (MSCs) to self-renew and their multipotentiality have rendered them attractive to researchers and clinicians. In addition to the differentiation potential, the broad repertoire...
8.
Whitt J, Vallabhaneni K, Penfornis P, Pochampally R
Curr Stem Cell Res Ther
. 2015 Oct;
11(2):141-8.
PMID: 26423301
Mesenchymal Stem/stromal cell (MSCs) transplantation procedures have been used since the 1960's to treat leukemia and other diseases, but due to the risks involved only patients with life threatening illnesses...
9.
Kollareddy M, Dimitrova E, Vallabhaneni K, Chan A, Le T, Chauhan K, et al.
Nat Commun
. 2015 Jun;
6:7389.
PMID: 26067754
Mutant p53 (mtp53) is an oncogene that drives cancer cell proliferation. Here we report that mtp53 associates with the promoters of numerous nucleotide metabolism genes (NMG). Mtp53 knockdown reduces NMG...
10.
Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y, et al.
J Biol Chem
. 2015 Feb;
290(15):9842-54.
PMID: 25691572
Brain is one of the major sites of metastasis in breast cancer; however, the pathological mechanism of brain metastasis is poorly understood. One of the critical rate-limiting steps of brain...